Mechanisms of synapse dysfunction in Alzheimer's disease

阿尔茨海默病突触功能障碍的机制

基本信息

批准号：
7742186
负责人：
JANE M SULLIVAN
金额：
$ 30.36万
依托单位：
UNIVERSITY OF WASHINGTON
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-12-15 至 2011-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7742186
关键词：
Action Potentials Affect Alzheimer&apos s Disease Amyloid beta-Protein Amyloid beta-Protein Precursor Area Biological Assay Biological Models Calcium Caspase Cells Cognitive deficits Depressed mood Disease Progression Enzymes Excitatory Synapse Fire - disasters Functional disorder Hippocampus (Brain)Imaging Techniques Insulin Receptor Knock-in Mouse Knockout Mice Knowledge Learning Ligands Link Literature Long-Term Effects Mediating Mental Depression Metabotropic Glutamate Receptors Molecular Molecular Target Mus N-Methyl-D-Aspartate Receptors Nerve Degeneration Neuraxis Neurons Neurotransmitters Nicotinic Receptors Pathway interactions Patients Positioning Attribute Preparation Production Protein Isoforms Proteins Proteolysis Research Resistance Role Semliki forest virus Signal Pathway Signal Transduction Small Interfering RNA Speed Staging Subfamily lentivirinae Surface Symptoms Synapses Synaptic Transmission System Techniques Testing Toxic effect Western Blotting Work aged cognitive function experience familial Alzheimer disease improved link protein mutant neurotransmission new therapeutic target novel optical imaging overexpression peptide A postsynaptic presenilin presynaptic receptor secretase synaptic function theories tool transmission process

项目摘要

DESCRIPTION (provided by applicant): A prominent theory about Alzheimer's disease (AD) proposes that early cognitive deficits are due to subtle alterations in synaptic transmission, but specific AD-related changes in synaptic transmission are not well understood. In order to better understand the role of synaptic deficits during the early stages of AD, we must study the effects of AD-related proteins on synaptic transmission in a mammalian central nervous system preparation. Two proteins that have been strongly implicated in AD-related synaptic dysfunction are amyloid precursor protein (APP) and presenilin. We have recently shown that overexpression of APP depresses synaptic transmission through both pre- and postsynaptic mechanisms, and that this depression depends on production of amyloid beta peptide (A?). It remains to be determined which specific isoform of A? (A?40 or A?42) is the relevant ligand, and which surface receptors (if any) is responsible mediating its effects. Presenilin is a critical component of ?-secretase, an enzyme required for A? production. Presenilin is also known to influence storage and release of calcium from internal stores. Changes in the levels of intracellular calcium are a critical signal for many pathways inside the cell, including signals that tell neurons how much neurotransmitter to release when they fire an action potential. Thus, changes in presenilin levels or function could affect synaptic transmission by altering either A? production or intracellular calcium levels. Our long-term objective is to develop a model system that will allow us to investigate the molecules and signaling pathways that are responsible for synaptic dysfunction underlying cognitive deficits associated with AD. We will focus initially on PS1 and APP. Specific Aim 1 of this proposal is to identify the role of wild-type PS1 in synaptic transmission and test the hypothesis that expression of Familial AD-linked mutant PS1 alters synaptic transmission. Specific Aim 2a is to determine whether elevated levels of secreted A?42 depress transmission at excitatory synapses, and whether either A240 or the caspase cleavage-resistant mutant APPD664A can reduce this depression. Specific Aim 2b is to identify the role of nicotinic acetylcholine receptors, NMDA receptors, group I metabotropic glutamate receptors, and insulin receptors in APP-mediated depression of synaptic transmission. Our experimental strategy is to use electrophysiological and optical imaging techniques to identify specific changes in neurotransmission produced by virally-mediated overexpression of wild-type and mutant forms of presenilin, APP, and APP-cleavage products in cultured mouse hippocampal neurons. Our lab has extensive experience studying the effects of virally-mediated overexpression of a variety of proteins on synaptic transmission in cultured hippocampal neurons, and is, therefore, in an excellent position to exploit this system to identify the effects of AD-related proteins on neurotransmission. These studies will provide molecular targets for novel therapies to improve cognitive function and delay further neurodegeneration in patients with early Alzheimer's disease. Alzheimer's disease is the most common cause of cognitive deficits in the aged, and is thought to begin with synaptic dysfunction. Understanding the cellular and molecular mechanisms underlying this synaptic dysfunction will provide new targets for therapeutic treatments to relieve symptoms, and slow or perhaps even stop disease progression.

描述（由申请人提供）：关于阿尔茨海默氏病（AD）的一个重要理论提出，早期认知缺陷是由于突触传递中的微妙改变造成的，但突触传递中与 AD 相关的特定变化尚不清楚。为了更好地了解AD早期突触缺陷的作用，我们必须研究AD相关蛋白对哺乳动物中枢神经系统制剂中突触传递的影响。与 AD 相关突触功能障碍密切相关的两种蛋白质是淀粉样前体蛋白 (APP) 和早老素。我们最近表明，APP 的过度表达通过突触前和突触后机制抑制突触传递，并且这种抑制取决于淀粉样β肽（A？）的产生。 A 的具体同种型仍有待确定？（Aβ40 或 Aβ42）是相关配体，哪些表面受体（如果有）负责介导其作用。早老素是 β-分泌酶的关键成分，β-分泌酶是 Aβ 所需的酶。生产。早老素还可以影响体内钙的储存和释放。细胞内钙水平的变化是细胞内许多通路的关键信号，包括告诉神经元在激发动作电位时释放多少神经递质的信号。因此，早老素水平或功能的变化可能通过改变A？生产或细胞内钙水平。我们的长期目标是开发一个模型系统，使我们能够研究导致 AD 相关认知缺陷的突触功能障碍的分子和信号通路。我们将首先关注 PS1 和 APP。该提案的具体目标 1 是确定野生型 PS1 在突触传递中的作用，并测试家族性 AD 相关突变体 PS1 的表达改变突触传递的假设。具体目标 2a 是确定分泌的 Aβ42 水平升高是否会抑制兴奋性突触的传递，以及 A240 或抗 caspase 裂解突变体 APPD664A 是否可以减少这种抑制。具体目标 2b 是确定烟碱乙酰胆碱受体、NMDA 受体、I 类代谢型谷氨酸受体和胰岛素受体在 APP 介导的突触传递抑制中的作用。我们的实验策略是使用电生理学和光学成像技术来识别由病毒介导的野生型和突变型早老素、APP 和 APP 裂解产物在培养的小鼠海马神经元中过度表达而产生的神经传递的具体变化。我们的实验室在研究病毒介导的多种蛋白质过度表达对培养的海马神经元突触传递的影响方面拥有丰富的经验，因此，在利用该系统来识别 AD 相关蛋白质对神经传递的影响方面处于有利地位。。这些研究将为新疗法提供分子靶点，以改善早期阿尔茨海默病患者的认知功能并延缓进一步的神经退行性变。阿尔茨海默病是老年人认知缺陷的最常见原因，被认为始于突触功能障碍。了解这种突触功能障碍背后的细胞和分子机制将为缓解症状、减缓甚至阻止疾病进展提供新的治疗目标。